| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/30/2008 | US20080269232 Pyridazine compound; also useful against rhinovirus |
| 10/30/2008 | US20080269231 Phenazine Compounds and Use Thereof in Autoimmune and Inflammatory Disease |
| 10/30/2008 | US20080269230 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 10/30/2008 | US20080269229 Serotonine, dopamine and norendrenaline receptors; antidepressants, anxiolytic agents, eating disorders; obesity; bipolar; drug abuse; neurodegenerative diseases |
| 10/30/2008 | US20080269228 Hydrazide-containing hepatitis c serine protease inhibitors |
| 10/30/2008 | US20080269227 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation |
| 10/30/2008 | US20080269226 Methods for Preserving Renal Function Using Xanthine Oxidoreductase Inhibitors |
| 10/30/2008 | US20080269225 Prokineticin 1 receptor antagonists |
| 10/30/2008 | US20080269224 Substituted Triazines as Prion Protein Ligands and Their Use to Detect or Remove Prions |
| 10/30/2008 | US20080269223 For antiepileptic agent; mixture with swelling agent, binders, fillers disintegrating agent |
| 10/30/2008 | US20080269222 Use of Delmopinol in the Treatment of Acne |
| 10/30/2008 | US20080269221 Antibacterial agents |
| 10/30/2008 | US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease |
| 10/30/2008 | US20080269219 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole |
| 10/30/2008 | US20080269218 using a triazole compound; anticancer agent |
| 10/30/2008 | US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 10/30/2008 | US20080269216 Gastrointestinal disorders; irritable bowel syndrome |
| 10/30/2008 | US20080269215 Bisamide Inhibitors of Hedgehog Signaling |
| 10/30/2008 | US20080269214 Therapy for bacteria infections |
| 10/30/2008 | US20080269213 8-Hydroxyquinoline compounds and methods thereof |
| 10/30/2008 | US20080269212 Anticancer agents |
| 10/30/2008 | US20080269211 Antiserotonine agents; gastrointestinal disorders; irritable bowel syndrome; central nervous system disorders; Alzheimer's disease; cognition activators; analgesics; cardiovascular disorders; antidiabetic agents; sleep disorders |
| 10/30/2008 | US20080269210 Using 1-(4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno(3,2-d)pyrimifin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfony)ethanone; lipid kinase inhibitor; anticancer agents |
| 10/30/2008 | US20080269209 P 38 map kinase inhibitor; autoimmune diseases; antiinflammatory agents; cardovascular disorders; bone disorders; neurodegenerative diseases; antiproliferative agents |
| 10/30/2008 | US20080269208 Antidepressant; schizophrenia; pyridine ring substituted with bicyclic nitrogen containing rings |
| 10/30/2008 | US20080269207 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide |
| 10/30/2008 | US20080269206 Cftr inhibitor compounds and uses thereof |
| 10/30/2008 | US20080269205 Methods to prevent vertical transmission of infectious diseases |
| 10/30/2008 | US20080269204 Benzolactam boronic acid compounds; blocking inflammatory cytokines and tumor necrosis ; phosphodiesterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders |
| 10/30/2008 | US20080269203 Compositions and methods relating to novel compounds and targets thereof |
| 10/30/2008 | US20080269202 Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents |
| 10/30/2008 | US20080269201 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; gastrointestinal disorders; eating disorders; antidiabetic agents; anticancer agents |
| 10/30/2008 | US20080269200 Antiinflammatory agents; tissue repair; rheumatic disorders; asthma; chronic onstructive pulmonary disease; osteoporosis; psoriasis; Alzheimer's disease; transplant rejection; stroke; antidiabetic agents; glomerulonephritis; anticancer agents |
| 10/30/2008 | US20080269199 Therapy for obesity, diabetes, sleep disorders, Alzheimer's disease, Parkinson's disease; attention deficit disorders; antiepileptic agents; schizophrenia; antidepressants; anxiolytic agents |
| 10/30/2008 | US20080269198 Oral administering; drug with carrier and excipient |
| 10/30/2008 | US20080269197 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia |
| 10/30/2008 | US20080269196 Serotonin receptor antagonist; therapy obesity, obsessive compulsive disorders; antidepressants; anxiolytic agents |
| 10/30/2008 | US20080269195 Compounds Having Affinity For the Dopamine D3 Receptor and Uses Thereof in Medicine |
| 10/30/2008 | US20080269194 Benzodiazepine compounds; controlling cell death, autoimmune diseases; antiinflammatory agents; antiproliferative agents; antiarthritic agents; multiple sclerosis;Crohn's disease; leukemia; inflammatory bowel disorders; anticancer, antitumor agents; asthma; psoriasis |
| 10/30/2008 | US20080269193 Inhibition of heat shock protein diseases; antiproliferative agents; antiarthritic agents; antiinflammatory agents; autoimmune diseases; stroke; antiischemic agents; cardiovascular disorders; antitumor agents; anticancer agenst |
| 10/30/2008 | US20080269192 Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds |
| 10/30/2008 | US20080269191 Compounds for Nonsense Suppression, Use of These Compounds for the Manufacture of a Medicament for Treating Somatic Mutation-Related Diseases |
| 10/30/2008 | US20080269190 Chronic obstructive pulmonary disease; asthma |
| 10/30/2008 | US20080269189 Method for Avoiding Edema in the Treatment or Prevention of Ppary-Responsive Diseases, Including Cancer |
| 10/30/2008 | US20080269188 Determine variable response in patients sensitive to cardiovascular disease, high cholesterol, diabetes, metabolism disorders; detecting concentration of polypeptide containing proline as indicator of good response to statin therapy; drug design |
| 10/30/2008 | US20080269187 Applying propylene glycol to ear with antibiotic, viricides, fungicide, antiinflammatory agents |
| 10/30/2008 | US20080269186 Using metal oxide complexes; skin disorders; cosmetics; interior coatings; medical equipment; air and water purification |
| 10/30/2008 | US20080269185 Methods Of Treating Oral Mucositis |
| 10/30/2008 | US20080269184 Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof |
| 10/30/2008 | US20080269183 Adjust permeability of bain-blood barrier; multiple sclerosis; Alzheimer's disease; Parkinson's disease; spinal cord injuries; antiischemic agents; stroke; adjust cholesterol metabolism; cardiovascular disorders |
| 10/30/2008 | US20080269182 Administering a histone deacetylase inhibitor and anticancer agents; administering by mouth |
| 10/30/2008 | US20080269181 Methods for treating a posterior segment of an eye |
| 10/30/2008 | US20080269180 Improving embryo score; administering to human female; harvesting, fertilization of oocytes and forming embryos; adjust concentration of prasterone |
| 10/30/2008 | US20080269179 Asthma, cystic fibrosis, cough, lung disease |
| 10/30/2008 | US20080269178 Antiinflammatory agents; heating glucocorticoid with water and surfactant |
| 10/30/2008 | US20080269176 New Salts |
| 10/30/2008 | US20080269175 Silicone permeated with therapeutic agents; butyl acetate solvent; minocycline, rifampin, clonidine, sulindac; drug-loaded polymeric boots, sheaths, discs; elute drug more rapidly |
| 10/30/2008 | US20080269173 Composition for Stimulating Growth of Dermal Papilla Cells and Promoting Hair Follicle Growth Comprising Vitamin C Derivatives |
| 10/30/2008 | US20080269172 (1-{5-[(4-amino-benzenesulfonyl)-isobutyl-amino]-6-phosphonooxy-hexacarbomoyl}-2,2-diphenyl-ethyl)-carbamic acid methyl ester; which upon cleavage of cleavable bond or unit generates HIV-1 aspartyl protease inhibitor; antiviral agent; good solubility, and bioavailability; HIV or HTLV infection |
| 10/30/2008 | US20080269170 Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors |
| 10/30/2008 | US20080269169 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 10/30/2008 | US20080269168 N-acetylglucosamine organic acid ester; glycosides; cosmetics |
| 10/30/2008 | US20080269167 Preparation Comprising Iron(III) Complex Compounds And Redox-Active Substance(s) |
| 10/30/2008 | US20080269166 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease |
| 10/30/2008 | US20080269165 Use of sulfated glycosaminoglycans for establishing effective labor in women |
| 10/30/2008 | US20080269164 Preparation and Application of Heparin Silver |
| 10/30/2008 | US20080269163 Methods and Compositions for Protecting Cells from Ultrasound-Mediated Cytolysis |
| 10/30/2008 | US20080269162 Sulphated or phosphated polysaccharide in combination with AZT, Viramune, Agnerase, enfuvirtide; anti-nausea agents, anti-diarrhea agents, anti-hyperbilirubinemia, analgesic, dermatological treatment agents, anti-nephrotoxic agents; lentiviruses, oncoviruses, HIV |
| 10/30/2008 | US20080269161 Compositions and Methods Relating to Mitochondrial Hyperpolarization in Neurological Disease |
| 10/30/2008 | US20080269160 Immune response against antigen in vivo; gold particle bombardment, nucleotide sequence encoding chimeric protein, antigen in one nucleic acid in an adenoviral vector; chimeric protein is myristoylation membrane targeting region; AP1903 ligand-binding region; CD40 cytoplasmic polypeptide region |
| 10/30/2008 | US20080269159 Compositions and methods for regulation of smooth muscle cells and blood pressure |
| 10/30/2008 | US20080269158 E2epf Ubiquitin Carrier Protein-Von Hippel-Lindau Interaction and Uses Thereof |
| 10/30/2008 | US20080269157 Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations |
| 10/30/2008 | US20080269156 Antisense strand, sense strand are non-phosphorylated at the 5' and 3' termini; pulmonary, eye, microvascular, hearing disorders; target for hypoxia-inducible factor-1 that may regulate hypoxia-induced pathogenesis independent of growth factors such as VEGF |
| 10/30/2008 | US20080269155 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 10/30/2008 | US20080269154 Mesencephalic astrocyte-derived neurotrophic factor; peripheral neuropathy; Alzheimer's disease; Parkinson's disease |
| 10/30/2008 | US20080269153 Biodegradable polymer of L-glutamic acid to stabilize DNA plasmid vaccine; optimized constant current electroporation delivery technique and a plasmid DNA composition prevents excessive cellular damage and degradation of the plasmid DNA during the electroporation delivery into muscle cells |
| 10/30/2008 | US20080269152 Nucleic acid binding oligonucleotides |
| 10/30/2008 | US20080269151 Antigen, nucleic acid that encodes fusion protein; diagnosis, prevention, therapy of tuberculosis |
| 10/30/2008 | US20080269150 Intra-vascular kidney gene therapy with plasmid encoding BMP-7 |
| 10/30/2008 | US20080269149 Adeno-associated virus (AAV); genetic engineering; parvoviruses; gene therapy; muscle delivery; glioblastoma; Parkinson's Disease |
| 10/30/2008 | US20080269148 Using vector comprising nucleotide sequences which interfere with viral gene expression for prevention and treatment of hepatitis c viral infection; gene expression inhibition |
| 10/30/2008 | US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene |
| 10/30/2008 | US20080269146 4''-Substituted Erythromycin Derivative |
| 10/30/2008 | US20080269145 broad spectrum antibiotic activity; Gram-positive bacteria such as Clostridium, Staphylococcus, Enterococcus species; comprises tiacumicin B, lipiarmycin A4, and at least one of other macrocyclic compounds |
| 10/30/2008 | US20080269144 Synthesis of Inhibitors of P90Rsk |
| 10/30/2008 | US20080269143 Dual delta and mu opioid receptor antagonist; 3,6-Bis(Boc-Dmt-Tic-NH-methyl)-2(1H)-pyrazinone |
| 10/30/2008 | US20080269140 Conformationally Constrained Smac Mimetics and the Uses Thereof |
| 10/30/2008 | US20080269135 Method of treatment for early stage cancer |
| 10/30/2008 | US20080269134 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 10/30/2008 | US20080269131 Protein kinase B ; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(2S)-2-morpholinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; cancer and arthritis |
| 10/30/2008 | US20080269129 Polypeptide and dna thereof useful as a neovascular marker |
| 10/30/2008 | US20080269121 Methods and Compositions Involving A1c Subunit of L-Type Calcium Channels in Smooth Muscle Cells |
| 10/30/2008 | US20080269112 Antineoplastic Agents Targeted via Glut Transporters |
| 10/30/2008 | US20080269111 Administering to a subject an apolipoprotein-sphingomyelin complex comprising an apolipoprotein and the lipid sphingomyelin in an amount effective to achieve a serum level of free or complexed apolipoprotein in the range of 30 mg/dL to 300 mg/dL after administration; treatment of cardiovascular disease |
| 10/30/2008 | US20080269110 Non-basic melanin concentrating hormone receptor-1 antagonists |
| 10/30/2008 | US20080269109 System and method of resuscitation of a mammal |
| 10/30/2008 | US20080269105 Useful delivery of drugs can be obtained through the association of drugs with certain polymers which are referred to as CYSC polymers (crystallizable side chain polymers) |
| 10/30/2008 | US20080268547 Systems and Methods for Indicating Oxidation of Consumer Products |
| 10/30/2008 | US20080268537 Free of nitrone; for reducing oxidative damage or delaying senescence |